The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of neoadjuvant bevacizumab plus pemetrexed and carboplatin in patients with unresectable stage III lung adenocarcinoma (GASTO 1001).
 
Si-Yu Wang
No Relationships to Disclose
 
Wei Ou
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Song-Liang Zhang
No Relationships to Disclose
 
Qian-Wen Liu
No Relationships to Disclose
 
Peng-Fei Xu
No Relationships to Disclose
 
Cheng Yuan
No Relationships to Disclose
 
Bao-Xiao Wang
No Relationships to Disclose